Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 2 5Phase 1 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Sarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Leukemia, Biphenotypic, Acute 1Degradation of Top2b and Top2a in Human by Dexrazoxane 1

Interventions

pembrolizumab 258Cyclophosphamide 247Specimen Handling 197fludarabine 176Magnetic Resonance Spectroscopy 171Biopsy 146Nivolumab 124Carboplatin 100Radiotherapy 92Paclitaxel 90venetoclax 82Cisplatin 82fludarabine phosphate 80Gemcitabine 79Injections 69Ipilimumab 65Dexamethasone 63atezolizumab 58Bevacizumab 58Fluorouracil 57Cetuximab 57Azacitidine 57Radiation 56durvalumab 55Radiosurgery 51Temozolomide 48Oxaliplatin 45Rituximab 44Irinotecan 44Docetaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Dexrazoxane × 1 year × Clear all
NCT05292664 2026-03-12

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Dana-Farber Cancer Institute

Phase 1 Recruiting
30 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05858710 2025-07-28

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Thermosome GmbH

Phase 1 Completed
8 enrolled
Sarcoma

Sarcoma

NCT03930680 2025-07-08

PHOENIX1

University of Arkansas

Phase 1 Completed
25 enrolled 9 charts

Degradation of Top2b and Top2a in Human by Dexrazoxane

Data powered by HemOnc (CC BY 4.0) Colophon âš¡